Research Article
Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin’s Lymphoma of the Duodenum: A SEER Database Analysis
Table 2
Comparison of clinicopathological parameters among PSLs, PGLs, and PSILs.
| | Clinicopathologic features | PDLs | PGLs | PSILs | | n = 1060 | n = 10573 | value | n = 3239 | value |
| | Age (years) | | | | | | | Mean ± SD | 60.96 ± 15.205 | 66.08 ± 14.957 | <0.001 | 62.41 ± 16.779 | 0.013 | | ≥60 | 578 (54.53) | 7205 (68.15) | <0.001 | 1927 (59.49) | 0.004 | | <60 | 482 (45.47) | 3368 (31.85) | | 1312 (40.51) | | | Gender | | | 0.016 | | 0.065 | | Male | 604 (56.98) | 5617 (53.13) | | 1931 (59.62) | | | Female | 456 (43.02) | 4956 (46.87) | | 1308 (40.38) | | | Ann Arbor staging | | | 0.071 | | <0.001 | | I | 564 (53.21) | 5616 (53.12) | | 1239 (38.25) | | | II | 182 (17.17) | 1541 (14.58) | | 1047 (32.32) | | | III | 40 (3.77) | 482 (4.56) | | 143 (4.41) | | | IV | 173 (16.32) | 1731 (16.37) | | 567 (17.52) | | | Unknown | 101 (9.53) | 1203 (11.37) | | 243 (7.50) | | | Symptoms | | | <0.001 | | <0.001 | | A | 463 (43.68) | 3260 (30.83) | | 1174 (36.25) | | | B | 127 (11.98) | 1313 (12.42) | | 432 (13.33) | | | Unknown | 470 (44.34) | 6000 (56.75) | | 1633 (50.42) | | | Histological type | | | <0.001 | | <0.001 | | DLBCL | 348 (32.83) | 5168 (48.88) | | 1778 (54.89) | | | MALT | 146 (13.77) | 4323 (40.89) | | 265 (8.18) | | | T-cell | 28 (2.64) | 78 (0.74) | | 185 (5.71) | | | FL | 436 (41.13) | 236 (2.23) | | 744 (22.97) | | | MCL | 29 (2.74) | 131 (1.24) | | 51 (1.57) | | | Unknown | 73 (6.89) | 637 (6.02) | | 216 (6.68) | | | Treatment modality | | | 0.38 | | <0.001 | | Only surgery | 41 (3.87) | 401 (3.79) | | 928 (28.65) | | | Surgery + conservative | 51 (4.81) | 619 (5.85) | | 1173 (36.22) | | | Conservative | 968 (91.32) | 9553 (90.36) | | 1138 (35.13) | |
|
|
DLBCL = diffuse large B-cell lymphoma; ETCL = T-cell lymphoma; FL = follicular lymphoma; MALT = mucosa-associated lymphoid tissue; MCL = mantle cell lymphoma.
|
